Importantly, studies have shown that reducing MCP-1 levels in mouse models of type 1 and type 2 diabetes mellitus can inhibit macrophage infiltration, thereby alleviating proteinuria and inflammatory markers (30). This evidence concerns the gene CCL2 and diabetes mellitus.